Author

Christopher J. Fraser

Observed names: C Fraser, C J Fraser, C. Fraser, C.J. Fraser, Christopher Fraser, Christopher J Fraser

Institutions: The University of Queensland, Children's Health Queensland Hospital and Health Service

Observed institutions: BC Cancer Agency, City Of Hope National Medical Center, University of Minnesota, Royal Children's Hospital, University of British Columbia, The University of Queensland, University of Michigan, UNSW Sydney, City of Hope, Michigan Medicine, Children's Health Queensland Hospital and Health Service, Saint Louis University

OpenAlex ID: A5044138491

Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study

2006 · Christopher J. Fraser, Smita Bhatia, et al. · Blood · 279

PDF

Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue

2000 · A.M. Wardley, G.C. Jayson, et al. · British Journal of Haematology · 220

Multisystem inflammation and susceptibility to viral infections in human ZNFX1 deficiency

2021 · Stefano Vavassori, Janet Chou, et al. · Journal of Allergy and Clinical Immunology · 85

PDF

First report of donor cell–derived acute leukemia as a complication of umbilical cord blood transplantation

2005 · Christopher J. Fraser, Betsy A. Hirsch, et al. · Blood · 63

Helical tomotherapy targeting total bone marrow – First clinical experience at the University of Minnesota

2006 · Susanta K. Hui, M. R. Verneris, et al. · Acta Oncologica · 57

PDF

Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors

2005 · C J Fraser, B J Weigel, et al. · Bone Marrow Transplantation · 57

Review of the Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Paediatric Patients

2020 · Rachael Lawson, Christine E. Staatz, et al. · Clinical Pharmacokinetics · 56

Quality of life and recovery after graft-versus-host disease

2008 · K. Scott Baker, Christopher J. Fraser · Best Practice & Research Clinical Haematology · 56

Outcome of Transplantation for Acute Myelogenous Leukemia in Children with Down Syndrome

2013 · Johann K. Hitzler, Wensheng He, et al. · Transplantation and Cellular Therapy · 51

Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study

2014 · I A Bilmon, L J Ashton, et al. · Bone Marrow Transplantation · 47

Outcome of transplantation for acute lymphoblastic leukemia in children with down syndrome

2014 · Johann K. Hitzler, Wensheng He, et al. · Pediatric Blood & Cancer · 41

The management and outcome of chronic graft‐versus‐host disease

2007 · Christopher J. Fraser, K. Scott Baker · British Journal of Haematology · 40

PDF

Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Population-Based Cohort Study

2016 · Claire M. Vajdic, Eleni Mayson, et al. · Transplantation and Cellular Therapy · 34

Pharmacokinetics, Safety, and Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Adolescent Hematopoietic Cell Transplantation Recipients

2024 · Andreas H. Groll, Johannes H. Schulte, et al. · The Pediatric Infectious Disease Journal · 30

Adoptive T-cell therapy for pediatric cytomegalovirus-associated retinitis

2019 · Shiney Seo, Corey Smith, et al. · Blood Advances · 22

PDF

Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

2025 · Andrew E. Place, Seth E. Karol, et al. · Pediatric Blood & Cancer · 18

PDF

Evaluation of two software using Bayesian methods for monitoring exposure and dosing once-daily intravenous busulfan in paediatric patients receiving haematopoietic stem cell transplantation

2021 · Rachael Lawson, Lachlan Paterson, et al. · Cancer Chemotherapy and Pharmacology · 18

Safety, Efficacy, and PK of the BCL2 Inhibitor Venetoclax in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Phase 1 Study

2019 · Seth E Karol, Todd M Cooper, et al. · Blood · 16

Population pharmacokinetic model for once‐daily intravenous busulfan in pediatric subjects describing time‐associated clearance

2022 · Rachael Lawson, Christine E. Staatz, et al. · CPT Pharmacometrics & Systems Pharmacology · 14

Development and Validation of a High Pressure Liquid Chromatography–UV Method for the Determination of Treosulfan and Its Epoxy Metabolites in Human Plasma and Its Application in Pharmacokinetic Studies

2015 · Sundar R. Koyyalamudi, Unnikrishnan Kuzhiumparambil, et al. · Journal of Chromatographic Science · 14

Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia Harboring Heterogeneous Genomic Profiles Respond to Venetoclax in Combination with Chemotherapy

2020 · Andrew E. Place, Seth E. Karol, et al. · Blood · 13

Correction of Wiskott-Aldrich Syndrome by Hematopoietic Stem Cell Gene Therapy

2010 · Kaan Boztug, Manfred Schmidt, et al. · Blood · 13

Survival from haematological malignancy in childhood, adolescence and young adulthood in Australia: is the age‐related gap narrowing?

2010 · Ross Pinkerton, Rachael‐Anne Wills, et al. · The Medical Journal of Australia · 13

Anaplastic large cell lymphoma of the pancreas: a pediatric case and literature review.

2004 · Christopher J Fraser, Yuen F Chan, et al. · PubMed · 12

Intrabronchial administration of activated recombinant factor VII in a young child with diffuse alveolar hemorrhage

2013 · P.J. Larcombe, N. Kapur, et al. · Pediatric Blood & Cancer · 11

Works count: 56

Citation count: 1,361

H-index: 17

I10-index: 26